Literature DB >> 16160472

Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant chemoradiotherapy.

Christiane Jakob1, Torsten Liersch, Wolfdietrich Meyer, Gustavo B Baretton, Peter Häusler, Wolfgang Schwabe, Heinz Becker, Daniela E Aust.   

Abstract

In locally advanced rectal cancer, neoadjuvant 5-fluorouracil (5-FU)-based long-term chemoradiotherapy leads to marked tumor reduction and decrease of local recurrence rate. Thymidylate synthase (TS), thymidine phosphorylase (TP), and dihydropyrimidine dehydrogenase (DPD) are known to be important biomarkers to predict tumor response to 5-FU-based therapy. The aim of this study was to examine the correlation between TS, TP, and DPD protein expression and histopathologic tumor regression after neoadjuvant chemoradiotherapy. The results were compared with the recently published mRNA data. Preoperative biopsies (n = 25) and resection specimens (n = 40) from patients with rectal carcinoma (clinical UICC stage II/III) receiving neoadjuvant 5-FU-based chemoradiotherapy were studied for TS, TP, and DPD protein expression by immunohistochemistry using three different scoring systems (intensity, pattern, intensity + pattern). Results were compared with histopathologic tumor regression. A significant correlation between protein expression and tumor response was only seen when both staining intensity and staining pattern were considered. With this method, a significant association was seen between high TS expression in tumor biopsies as well as resection specimens and nonresponse of the tumor to therapy (P = 0.04). Furthermore, low TP expression in the resection specimens was significantly associated with lack of response (P = 0.02). For DPD no significant correlations were found at all. In conclusion, these results suggest that immunohistochemistry like RT-PCR is a suitable method to determine the correlation between TS, TP, and DPD expression and histopathologic tumor regression. However, precise results can only be achieved if staining intensity as well as staining pattern within the tumors are evaluated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160472     DOI: 10.1097/01.pas.0000170346.55304.88

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  17 in total

1.  Is 3'-deoxy-3'-(18)F-fluorothymidine a better marker for tumour response than (18)F-fluorodeoxyglucose?

Authors:  Sven N Reske; Sandra Deisenhofer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

Review 2.  [Individualizing treatment for locally advanced rectal cancer].

Authors:  T Liersch; H Rothe; B M Ghadimi; H Becker
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

3.  Systems pharmacology assessment of the 5-fluorouracil pathway.

Authors:  Filipe A Muhale; Barbara A Wetmore; Russell S Thomas; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2011-03       Impact factor: 2.533

4.  p27 expression in post-treatment rectal cancer: a potential novel approach for predicting residual nodal disease.

Authors:  Tobias Leibold; Vanessa W Hui; Jinru Shia; Jeannine A Ruby; Elyn R Riedel; José G Guillem
Journal:  Am J Surg       Date:  2014-04-13       Impact factor: 2.565

5.  Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy.

Authors:  Marian Grade; Jochen Gaedcke; Danny Wangsa; Sudhir Varma; Jaje Beckmann; Torsten Liersch; Clemens Hess; Heinz Becker; Michael J Difilippantonio; Thomas Ried; B Michael Ghadimi
Journal:  Cancer Genet Cytogenet       Date:  2009-08

6.  Nuclear thymidylate synthase expression in sporadic colorectal cancer depends on the site of the tumor.

Authors:  Violetta Sulzyc-Bielicka; Pawel Domagala; Ewa Majdanik; Maria Chosia; Dariusz Bielicki; Jozef Kladny; Mariusz Kaczmarczyk; Krzysztof Safranow; Wenancjusz Domagala
Journal:  Virchows Arch       Date:  2009-05-15       Impact factor: 4.064

7.  Thymidine phosphorylase and hypoxia-inducible factor 1-α expression in clinical stage II/III rectal cancer: association with response to neoadjuvant chemoradiation therapy and prognosis.

Authors:  Shuhan Lin; Hao Lai; Yuzhou Qin; Jiansi Chen; Yuan Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy.

Authors:  Christiane Jakob; Torsten Liersch; Wolfdietrich Meyer; Heinz Becker; Gustavo-B Baretton; Daniela-E Aust
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

9.  High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction.

Authors:  M Kikuchi; T Mikami; T Sato; W Tokuyama; K Araki; M Watanabe; K Saigenji; I Okayasu
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

10.  Pharmacokinetic and Pharmacodynamic Analyses of 5-Fluorouracil in East-Asian Patients with Nasopharyngeal Carcinoma.

Authors:  Yuxiang Ma; Yuehao Lin; Benyan Zou; Wanli Liu; Yang Zhang; Liping Zhao; Yan Huang; Yunpeng Yang; Wenfeng Fang; Yuanyuan Zhao; Jin Sheng; Tao Qin; Zhihuang Hu; Salavatore J Salamone; Yunying Li; Li Zhang; Hongyun Zhao
Journal:  Clin Pharmacokinet       Date:  2016-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.